Dr. Mark A. Exley shares what excites him most about joining LIfT as Chief Scientific Officer and the potential of LIfT’s technology

In this video, Dr. Mark A. Exley shares his background in biotech, what makes our neutrophil-based approach to cancer therapy so effective and what he hopes to achieve in his role as Chief Scientific Officer.